Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1963 4
1964 5
1965 51
1966 85
1967 95
1968 102
1969 87
1970 85
1971 92
1972 52
1973 63
1974 66
1975 77
1976 76
1977 80
1978 114
1979 82
1980 87
1981 101
1982 95
1983 109
1984 99
1985 122
1986 106
1987 121
1988 110
1989 138
1990 145
1991 150
1992 147
1993 185
1994 145
1995 173
1996 187
1997 196
1998 191
1999 192
2000 166
2001 159
2002 210
2003 204
2004 206
2005 245
2006 248
2007 288
2008 260
2009 276
2010 306
2011 390
2012 402
2013 411
2014 419
2015 443
2016 442
2017 492
2018 465
2019 497
2020 593
2021 568
2022 719
2023 594
2024 252

Text availability

Article attribute

Article type

Publication date

Search Results

12,208 results

Results by year

Filters applied: . Clear all
Page 1
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F; French Sarcoma Group. Pautier P, et al. Lancet Oncol. 2022 Aug;23(8):1044-1054. doi: 10.1016/S1470-2045(22)00380-1. Epub 2022 Jul 11. Lancet Oncol. 2022. PMID: 35835135 Clinical Trial.
[Sarcoma].
Iwata S, Katoh Y, Kawai A. Iwata S, et al. Gan To Kagaku Ryoho. 2020 Jul;47(7):1016-1019. Gan To Kagaku Ryoho. 2020. PMID: 32668842 Japanese.
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
Koch R, Gelderblom H, Haveman L, Brichard B, Jürgens H, Cyprova S, van den Berg H, Hassenpflug W, Raciborska A, Ek T, Baumhoer D, Egerer G, Eich HT, Renard M, Hauser P, Burdach S, Bovee J, Bonar F, Reichardt P, Kruseova J, Hardes J, Kühne T, Kessler T, Collaud S, Bernkopf M, Butterfaß-Bahloul T, Dhooge C, Bauer S, Kiss J, Paulussen M, Hong A, Ranft A, Timmermann B, Rascon J, Vieth V, Kanerva J, Faldum A, Metzler M, Hartmann W, Hjorth L, Bhadri V, Dirksen U. Koch R, et al. J Clin Oncol. 2022 Jul 20;40(21):2307-2320. doi: 10.1200/JCO.21.01942. Epub 2022 Apr 15. J Clin Oncol. 2022. PMID: 35427190 Clinical Trial.
Role of Immunotherapy in Sarcomas.
Dalal S, Shan KS, Thaw Dar NN, Hussein A, Ergle A. Dalal S, et al. Int J Mol Sci. 2024 Jan 19;25(2):1266. doi: 10.3390/ijms25021266. Int J Mol Sci. 2024. PMID: 38279265 Free PMC article. Review.
Chemotherapy for soft tissue sarcoma.
Ratan R, Patel SR. Ratan R, et al. Cancer. 2016 Oct;122(19):2952-60. doi: 10.1002/cncr.30191. Epub 2016 Jul 19. Cancer. 2016. PMID: 27434055 Free article. Review.
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S. Palmerini E, et al. Cancer. 2023 Nov 15;129(22):3564-3573. doi: 10.1002/cncr.34964. Epub 2023 Aug 2. Cancer. 2023. PMID: 37530385
12,208 results
You have reached the last available page of results. Please see the User Guide for more information.